These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
156 related items for PubMed ID: 8786533
1. Tachykinin peptides affect differently the second messenger pathways after binding to CHO-expressed human NK-1 receptors. Sagan S, Chassaing G, Pradier L, Lavielle S. J Pharmacol Exp Ther; 1996 Mar; 276(3):1039-48. PubMed ID: 8786533 [Abstract] [Full Text] [Related]
7. Characterization of receptors mediating contraction induced by tachykinins in the guinea-pig isolated common bile duct. Patacchini R, Barthó L, Maggi CA. Br J Pharmacol; 1997 Dec; 122(8):1633-8. PubMed ID: 9422808 [Abstract] [Full Text] [Related]
10. The N-terminal domain of substance P is required for complete homologous desensitization but not phosphorylation of the rat neurokinin-1 receptor. Vigna SR. Neuropeptides; 2001 Feb; 35(1):24-31. PubMed ID: 11346307 [Abstract] [Full Text] [Related]
11. Further evidence for the presence of "septide-sensitive" tachykinin binding sites in tissues possessing solely NK(1) tachykinin receptors. Torrens Y, Beaujouan JC, Saffroy M, Glowinski J. Biochem Biophys Res Commun; 2000 Apr 13; 270(2):668-72. PubMed ID: 10753681 [Abstract] [Full Text] [Related]
12. Binding of the novel ligand [4,5-3H-Leu10]substance P to high-affinity NK-1 receptors on guinea pig lung membranes: modulation by GTP analogs and sulfhydryl modifying agents. Aharony D, Catanese CA, Woodhouse DP. J Pharmacol Exp Ther; 1991 Oct 13; 259(1):146-55. PubMed ID: 1717678 [Abstract] [Full Text] [Related]
13. Incorporation of vinylogous scaffolds in the C-terminal tripeptide of substance P. Claudel S, Tasseau O, Sagan S, Grison C, Coutrot P, Lavielle S. J Pept Res; 2004 Nov 13; 64(5):186-93. PubMed ID: 15485556 [Abstract] [Full Text] [Related]
14. Evidence for tachykinin NK-2 receptors in guinea-pig airways from binding and functional studies, using [125I]-[Lys5,Tyr(I2)7,MeLeu9,Nle10]-NKA(4-10). Zeng XP, Lavielle S, Burcher E. Neuropeptides; 1994 Jan 13; 26(1):1-9. PubMed ID: 7512696 [Abstract] [Full Text] [Related]
15. Characterization of tachykinin receptors in the uterus of the oestrogen-primed rat. Magraner J, Pinto FM, Anselmi E, Hernandez M, Perez-Afonso R, Martín JD, Advenier C, Candenas ML. Br J Pharmacol; 1998 Jan 13; 123(2):259-68. PubMed ID: 9489614 [Abstract] [Full Text] [Related]
16. Signal transduction mechanisms of recombinant bovine neurokinin-2 receptor stably expressed in baby hamster kidney cells. Eistetter HR, Mills A, Arkinstall SJ. J Cell Biochem; 1993 May 13; 52(1):84-91. PubMed ID: 8391539 [Abstract] [Full Text] [Related]
17. Point mutation increases a form of the NK1 receptor with high affinity for neurokinin A and B and septide. Ciucci A, Palma C, Manzini S, Werge TM. Br J Pharmacol; 1998 Sep 13; 125(2):393-401. PubMed ID: 9786514 [Abstract] [Full Text] [Related]
18. Isolation and pharmacological characterization of a hamster urinary bladder neurokinin A receptor cDNA. Aharony D, Little J, Thomas C, Powell S, Berry D, Graham A. Mol Pharmacol; 1994 Jan 13; 45(1):9-19. PubMed ID: 8302285 [Abstract] [Full Text] [Related]
19. Pharmacological characterization of ZD6021: a novel, orally active antagonist of the tachykinin receptors. Rumsey WL, Aharony D, Bialecki RA, Abbott BM, Barthlow HG, Caccese R, Ghanekar S, Lengel D, McCarthy M, Wenrich B, Undem B, Ohnmacht C, Shenvi A, Albert JS, Brown F, Bernstein PR, Russell K. J Pharmacol Exp Ther; 2001 Jul 13; 298(1):307-15. PubMed ID: 11408556 [Abstract] [Full Text] [Related]
20. Pharmacological characterization of the pressor response to tachykinins in isolated perfused rat kidney. Chen Y, Hoover DB. J Pharmacol Exp Ther; 1993 Dec 13; 267(3):1176-80. PubMed ID: 7505328 [Abstract] [Full Text] [Related] Page: [Next] [New Search]